13th Mar 2014 09:50
12 March 2014
ECO Animal Health Group plc
(“ECO” or the “Company”)
Issue of Equity
The Company has applied for 13,300 ordinary shares (“New Ordinary Shares”) to be admitted to trading on AIM following the exercise of options by an employee (“Admission”). It is expected that dealings in the New Ordinary Shares will commence at 08.00a.m on 18 March 2014.
Following Admission, the Company’s issued share capital will consist of 62,474,231 ordinary shares. This figure of 62,474,231 ordinary shares may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
| Contacts: | |||||
| ECO Animal Health Group plc | Marc Loomes 020 8447 8899 | ||||
| Spiro Financial | Anthony Spiro 020 8336 6196 | ||||
| Cenkos Securities plc | Stephen Keys 020 7397 8926 | ||||
| (Nominated Adviser) |
ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.
Copyright Business Wire 2014
Related Shares:
Eco Animal